Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by personalon Nov 06, 2018 12:03pm
270 Views
Post# 28931153

has anyone tried talking to Fred?

has anyone tried talking to Fred?Has he said what the next caltalyst will be and when, I know he keeps on saying they are working on partnerships but when I press him on that, we have been hearing this for a couple of years and that the balance sheet need shoring up, he agrees and again cannot comment.
I appreciate that he cannot comment until something is signed but this is death by a thousand cuts.
I think big pharma has come and gone, I am not a basher but this is very frustrating.
The silence is deafining.

Bullboard Posts